Exploring architectures displaying multimeric presentations of a trihydroxypiperidine iminosugar

Scholarly Works

• Tran, M. L.; Borie-Guichot, M.; Garcia, V.; Oukhrib, A.; Génisson, Y.; Levade, T.; Ballereau, S.; Turrin, C.-O.; Dehoux, C. Phosphorus Dendrimers for Metal-Free Ligation: Design of Multivalent Pharmacological Chaperones against Gaucher Disease. Chemistry (Weinheim an der Bergstrasse, Germany) 2023, 29, e202301210. doi:10.1002/chem.202301210
• Davighi, M. G.; Matassini, C.; Goti, A.; Ferraroni, M.; Angeli, A.; Supuran, C. T.; Cardona, F. Mono- and three-tailed sugar and iminosugar decorated benzenesulfonamide carbonic anhydrase inhibitors. Organic & biomolecular chemistry 2023, 21, 4491–4503. doi:10.1039/d3ob00529a
• Vanni, C.; Clemente, F.; Paoli, P.; Morrone, A.; Matassini, C.; Goti, A.; Cardona, F. 3,4,5-Trihydroxypiperidine Based Multivalent Glucocerebrosidase (GCase) Enhancers. Chembiochem : a European journal of chemical biology 2022, 23, e202200077. doi:10.1002/cbic.202200077
• González-Cuesta, M.; Mellet, C. O.; Fernández, J. M. G. Carbohydrate supramolecular chemistry: beyond the multivalent effect. Chemical communications (Cambridge, England) 2020, 56, 5207–5222. doi:10.1039/d0cc01135e
• Clemente, F.; Matassini, C.; Faggi, C.; Giachetti, S.; Cresti, C.; Morrone, A.; De Paoli, P.; Goti, A.; Martínez-Bailén, M.; Cardona, F. Glucocerebrosidase (GCase) activity modulation by 2-alkyl trihydroxypiperidines: Inhibition and pharmacological chaperoning. Bioorganic chemistry 2020, 98, 103740. doi:10.1016/j.bioorg.2020.103740
• Mohamed, S.; He, Q. Q.; Singh, A. A.; Ferro, V. Mucopolysaccharidosis type II (Hunter syndrome): Clinical and biochemical aspects of the disease and approaches to its diagnosis and treatment. Advances in carbohydrate chemistry and biochemistry 2019, 77, 71–117. doi:10.1016/bs.accb.2019.09.001
• Prichard, K. L.; O'Brien, N.; Ghorbani; Wood, A.; Barnes, E.; Kato, A.; Houston, T. A.; Simone, M. I. Synthetic Routes to 3,4,5‐Trihydroxypiperidines via Stereoselective and Biocatalysed Protocols, and Strategies to N‐ and O‐Derivatisation. European Journal of Organic Chemistry 2018, 2018, 6830–6842. doi:10.1002/ejoc.201801011
• Prichard, K. L.; Campkin, D.; O'Brien, N.; Kato, A.; Fleet, G. W. J.; Simone, M. I. Biological activities of 3,4,5-trihydroxypiperidines and their N- and O-derivatives. Chemical biology & drug design 2018, 92, 1171–1197. doi:10.1111/cbdd.13182
• Mirabella, S.; D'Adamio, G.; Matassini, C.; Goti, A.; Delgado, S.; Gimeno, A.; Robina, I.; Moreno-Vargas, A. J.; Šesták, S.; Jiménez-Barbero, J.; Cardona, F. Mechanistic Insight into the Binding of Multivalent Pyrrolidines to α-Mannosidases. Chemistry (Weinheim an der Bergstrasse, Germany) 2017, 23, 14585–14596. doi:10.1002/chem.201703011
• Matassini, C.; Parmeggiani, C.; Cardona, F.; Goti, A. Are enzymes sensitive to the multivalent effect? Emerging evidence with glycosidases. Tetrahedron Letters 2016, 57, 5407–5415. doi:10.1016/j.tetlet.2016.10.080
• Hottin, A.; Wright, D. W.; Moreno-Clavijo, E.; Moreno-Vargas, A. J.; Davies, G. J.; Behr, J.-B. Exploring the divalent effect in fucosidase inhibition with stereoisomeric pyrrolidine dimers. Organic & biomolecular chemistry 2016, 14, 4718–4727. doi:10.1039/c6ob00647g
• D'Adamio, G.; Matassini, C.; Parmeggiani, C.; Catarzi, S.; Morrone, A.; Goti, A.; De Paoli, P.; Cardona, F. Evidence for a multivalent effect in inhibition of sulfatases involved in lysosomal storage disorders (LSDs). RSC Advances 2016, 6, 64847–64851. doi:10.1039/c6ra15806d

Explore citations to this article at